Grants

Current

1) NIH/NIGMS # 1R16GM165398-01. Discovery of novel pentacyclic indolocyclopentaphthalazinone PARP1 inhibitors.

Role: Principal Investigator 

Budget period: 8/1/2026 – 7/31/2030   

2) NIH/NCI # R01-CA259037-01. Tuning PARP-1 retention and release on DNA breaks         

Role: Co-Investigator 

Budget period: 03/1/2022 – 02/28/2027

Completed

1) NIH/NIGMS # 1SC3GM131971-01. Development of PARP-isoform selective inhibitory chemical probes.         

Role: Principal Investigator 

Budget period: 7/3/2019 – 6/30/2024

2) UCSF # CA-0133030. Development of dual HDAC/PARP inhibitors. 

Role: Principal Investigator

Budget period: 6/1/2019 – 12/31/2024